Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2012-04-24 | Karen L. Shoos has been a director of Celldex since May 2001. The Board of Directors has established a Compensation Committee currently consisting of Karen L. Shoos, Chairman, George O. Elston and Harry H. Penner, Jr. The Board of Directors has established a Nominating and Corporate Governance Committee consisting of Herbert J. Conrad, Chairman, Larry Ellberger and Karen L. Shoos. The following table summarizes the annual compensation for our non-employee directors during 2011. Karen L. Shoos Fees Earned or Paid in Cash $95,417 Stock Awards $6,480 Total $101,897 |
| 2013-04-23 | Karen L. Shoos has been a director of Celldex since May 2001. The Board of Directors has established a Compensation Committee currently consisting of Karen L. Shoos, Chair, George O. Elston and Harry H. Penner, Jr. The Board of Directors has established a Nominating and Corporate Governance Committee consisting of Herbert J. Conrad, Chair, Larry Ellberger and Karen L. Shoos. The following table summarizes the annual compensation for our non-employee directors during 2012. Karen L. Shoos Fees Earned or Paid in Cash $100,000 Stock Awards $9,000 Total $109,000 |
| 2014-04-09 | Karen L. Shoos 60 2001 The Board of Directors has established a Compensation Committee currently consisting of Karen L. Shoos, Chair, George O. Elston and Harry H. Penner, Jr. The Board of Directors has established a Nominating and Corporate Governance Committee consisting of Herbert J. Conrad, Chair, Larry Ellberger and Karen L. Shoos. The following table summarizes the annual compensation for our non-employee directors during 2013. Karen L. Shoos 100,000 30,400 19,481 149,881 |
| 2015-04-23 | Karen L. Shoos has been a director of Celldex since May 2001. The Compensation Committee currently consists of Karen L. Shoos, Chair, George O. Elston, Harry H. Penner, Jr. and Richard van den Broek. The Nominating and Corporate Governance Committee currently consists of Herbert J. Conrad, Chair, Karen L. Shoos and Richard van den Broek. The following table summarizes the annual compensation for our non- employee directors during 2014. Karen L. Shoos Fees Earned or Paid in Cash $100,000 Stock Awards $26,900 Option Awards $17,370 Total $144,270. |
| 2016-04-21 | Karen L. Shoos Age 62 Year First Became Director 2001. Ms. Shoos is Chair of the Compensation Committee and member of the Nominating and Corporate Governance Committee. Director Compensation Table shows total compensation $425,975. |
| 2017-04-28 | Karen L. Shoos has been a director of Celldex since May 2001. The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Karen L. Shoos, Chair, Herbert J. Conrad and Larry Ellberger. The following table summarizes the annual compensation for our non-employee directors during 2016. Karen L. Shoos Fees Earned or Paid in Cash $77,500 Stock Awards $47,200 Option Awards $47,256 Total $171,956 |
| 2018-04-30 | Karen L. Shoos Age 64 Year First Became Director 2001 The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Karen L. Shoos, Chair, Herbert J. Conrad and Larry Ellberger. The following table summarizes the annual compensation for our non-employee directors during 2017. Karen L. Shoos Fees Earned or Paid in Cash $70,000 Stock Awards $23,200 Option Awards $23,345 Total $116,545 |
| 2019-04-26 | Karen L. Shoos has been a director since May 2001. She is Chair of the Nominating and Corporate Governance Committee. Compensation for 2018 was $88,219. |
| 2020-04-28 | Karen L. Shoos (Chair of the Board) Age 66 Year First Became Director 2001 Ms. Shoos is currently a consultant in international blood safety and since November 2015, Ms. Shoos has been the Director of Operations for the Maryland Tech Council Venture Mentoring Services Program. She was Chair of the Board since June 2019. The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Herbert J. Conrad, Chair, Keith L. Brownlie and Karen L. Shoos. The following table summarizes the annual compensation for our non-employee directors during 2019. Karen L. Shoos received $66,228 in fees and $9,386 in option awards, totaling $75,614. |
| 2021-04-27 | Karen L. Shoos was appointed Chair of the Board of Directors in June 2019 and has been a director of Celldex since May 2001. Ms. Shoos is currently a consultant in international blood safety and since November 2015, Ms. Shoos has been the Director of Operations for the Maryland Tech Council Venture Mentoring Services Program. ... The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Herbert J. Conrad, Chair, Keith L. Brownlie and Karen L. Shoos. ... The following table summarizes the annual compensation for our non-employee directors during 2020. Karen L. Shoos Fees Earned or Paid in Cash $74,000 Option Awards $87,586 Total $161,586. |
| 2022-04-26 | Karen L. Shoos was appointed Chair of the Board of Directors in June 2019 and has been a director of Celldex since May 2001. Ms. Shoos is currently a consultant in international blood safety and since November 2015, Ms. Shoos has been the Director of Operations for the Maryland Tech Council Venture Mentoring Services Program. ... The Board of Directors has established a Nominating and Corporate Governance Committee currently consisting of Herbert J. Conrad, Chair, Keith L. Brownlie and Karen L. Shoos. ... The following table summarizes the annual compensation for our non-employee directors during 2021. ... Karen L. Shoos Fees Earned or Paid in Cash ($) 74,000 Option Awards ($) 260,828 Total ($) 334,828. |
| 2023-04-25 | Karen L. Shoos (Chair of the Board) 69 2001 1 Karen L. Shoos was appointed Chair of the Board of Directors in June 2019 and became a director of Celldex in March 2008 with the merger of Celldex and AVANT. Ms. Shoos was appointed to the Board of AVANT in May 2001. Effective June 2022, Directors who are not our employees are each entitled to receive a retainer fee of $43,200 each fiscal year ("Annual Retainer"). The Chair of the Board is entitled to receive an annual retainer fee of $35,000 in addition to his or her Annual Retainer and any retainer for committee service. The following table summarizes the annual compensation for our non-employee directors during 2022. Karen L. Shoos Fees Earned or Paid in Cash ($) 76,979 Option Awards ($) 231,866 Total ($) 308,845 |
| 2024-04-25 | Effective June 2022, Directors who are not our employees are each entitled to receive a retainer fee of $43,200 each fiscal year ("Annual Retainer"). The Chair of the Board is entitled to receive an annual retainer fee of $35,000 in addition to his or her Annual Retainer and any retainer for committee service. The Chairperson of the Audit Committee, Compensation and Organization Development Committee and Nominating and Corporate Governance Committee of the Board of Directors is entitled to receive an annual retainer fee of $20,000, $15,000 and $10,000, respectively, in addition to his or her Annual Retainer. Each committee member of the Audit Committee, Compensation and Organization Development Committee and Nominating and Corporate Governance Committee (other than the Chairperson of a committee) will receive an annual retainer of $10,000, $7,500 and $5,000, respectively, in addition to his or her Annual Retainer. Stipends and retainers are paid in advance on a quarterly basis. The Directors shall be reimbursed for necessary travel and business expenses as incurred but will not receive any additional fees for attending meetings or calls of the Board of Directors. |
Data sourced from SEC filings. Last updated: 2025-08-30